Volume Alert - GILD 100.39 Gilead Sciences $GILD H
Post# of 162
Posted On: 11/14/2014 11:07:12 AM
Volume Alert - GILD 100.39 Gilead Sciences $GILD Hit a high today of 103.79 Closing the day 10:30 at 100.39 -3.81 -3.66% With a day low of 100.06 and a total volume of 8,270,259.
GILD Recent Posts: http://investorshangout.com/Gilead-Sciences-Inc-GILD-54232/
GILD Gilead Sciences Recent Headline News
Early Glance: Biotechnology companies
AP - 19 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Gilead Sciences (GILD) Crosses Pivot Point Support at $102.79
Comtex SmarTrend(R) - 1 hr 9 mins ago
Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $104.92 and have already reached the first level of support at $102.79. Investors may be interested in a cross of the next downside pivot targets of $101.38 and $97.84.
GILD: 101.28 (-2.92)
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Alexander J. Poulos - Seeking Alpha - 1 hr 43 mins ago
It is not often for one to come across such an explosive growth company such as Gilead Sciences (NASDAQ: GILD ). By virtue of its stronghold on the Hepatitis C market (HCV) combined with its dominant share in the HIV market, GILD has many...
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), SNY: 46.49 (-0.04), REGN: 400.16 (-2.47)
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - 1 hr 56 mins ago
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.28 (-2.92), IBIO: 1.10 (+0.02), ARIA: 6.18 (-0.07), MNKD: 6.23 (+0.05), CELG: 103.40 (-4.03)
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
PR Newswire - 2 hrs 21 mins ago
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: BlackBerry (NASDAQ:BBRY), Twitter (NYSE:TWTR), Alibaba (NYSE:BABA), Sirius XM (NASDAQ:SIRI), Gilead Sciences (NASDAQ:GILD), and JD.Com (NASDAQ:JD).
GILD: 101.28 (-2.92), BBRY: 11.63 (-0.43), JD: 26.45 (-0.87), TWTR: 40.69 (+0.65), SIRI: 3.52 (+0.01), BABA: 114.69 (-0.15)
The Post AASLD Annual Meeting Hepatitis C Landscape
Leonard Yaffe - at Seeking Alpha - Fri Nov 14, 5:15AM CST
JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), MRK: 58.97 (-0.57), ABBV: 63.44 (-0.19)
If Gilead Has The Ace, Is AbbVie Holding The Big Joker?
Shock Exchange - at Seeking Alpha - Fri Nov 14, 1:55AM CST
GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Most active Nasdaq-traded stocks
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.28 (-2.92), FB: 74.57 (+0.32), CMCSK: 54.05 (+0.02), ZNGA: 2.71 (-0.02), MSFT: 49.93 (+0.32), INTC: 33.87 (+0.19), GRPN: 7.79 (+0.02), CMCSA: 54.21 (-0.09), AAPL: 113.95 (+1.13), SUSQ: 13.12 (+0.06), CSCO: 26.05 (+0.37)
Final Glance: Biotechnology companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Midday Glance: Biotechnology companies
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Gilead prices debt offering
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:19AM CST
GILD: 101.28 (-2.92)
Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:44AM CST
Gilead Sciences which is in the Biotechnology space, saw EPS growth of nearly 11% last year, and is looking great for this year too.
GILD: 101.28 (-2.92)
Gilead prices USD4bn senior unsecured notes in three tranches
M2 - Thu Nov 13, 6:01AM CST
Biopharmaceutical company Gilead Sciences (NasdaqGS:GILD) said on Wednesday that it has priced its USD4bn senior unsecured notes in a public offering.
GILD: 101.28 (-2.92)
Gilead Prices $4 Billion of Senior Unsecured Notes
Business Wire - Wed Nov 12, 4:59PM CST
Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches:
GILD: 101.28 (-2.92)
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:00PM CST
Gilead Sciences, Inc. (GILD) announced pooled data from certain phase II and phase III studies evaluating Harvoni.
AGN: 197.30 (+1.09), JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Gilead Sciences Falls 1.03% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)
Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 1.03% Sell Off
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)
Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
Small Pharma Analyst - at Seeking Alpha - Wed Nov 12, 2:25PM CST
GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View
Shock Exchange - at Seeking Alpha - Wed Nov 12, 2:13PM CST
GILD: 101.28 (-2.92), MRK: 58.97 (-0.57)
GILD Recent Posts: http://investorshangout.com/Gilead-Sciences-Inc-GILD-54232/
GILD Gilead Sciences Recent Headline News
Early Glance: Biotechnology companies
AP - 19 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Gilead Sciences (GILD) Crosses Pivot Point Support at $102.79
Comtex SmarTrend(R) - 1 hr 9 mins ago
Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $104.92 and have already reached the first level of support at $102.79. Investors may be interested in a cross of the next downside pivot targets of $101.38 and $97.84.
GILD: 101.28 (-2.92)
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Alexander J. Poulos - Seeking Alpha - 1 hr 43 mins ago
It is not often for one to come across such an explosive growth company such as Gilead Sciences (NASDAQ: GILD ). By virtue of its stronghold on the Hepatitis C market (HCV) combined with its dominant share in the HIV market, GILD has many...
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), SNY: 46.49 (-0.04), REGN: 400.16 (-2.47)
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - 1 hr 56 mins ago
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.28 (-2.92), IBIO: 1.10 (+0.02), ARIA: 6.18 (-0.07), MNKD: 6.23 (+0.05), CELG: 103.40 (-4.03)
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
PR Newswire - 2 hrs 21 mins ago
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: BlackBerry (NASDAQ:BBRY), Twitter (NYSE:TWTR), Alibaba (NYSE:BABA), Sirius XM (NASDAQ:SIRI), Gilead Sciences (NASDAQ:GILD), and JD.Com (NASDAQ:JD).
GILD: 101.28 (-2.92), BBRY: 11.63 (-0.43), JD: 26.45 (-0.87), TWTR: 40.69 (+0.65), SIRI: 3.52 (+0.01), BABA: 114.69 (-0.15)
The Post AASLD Annual Meeting Hepatitis C Landscape
Leonard Yaffe - at Seeking Alpha - Fri Nov 14, 5:15AM CST
JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), MRK: 58.97 (-0.57), ABBV: 63.44 (-0.19)
If Gilead Has The Ace, Is AbbVie Holding The Big Joker?
Shock Exchange - at Seeking Alpha - Fri Nov 14, 1:55AM CST
GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Most active Nasdaq-traded stocks
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.28 (-2.92), FB: 74.57 (+0.32), CMCSK: 54.05 (+0.02), ZNGA: 2.71 (-0.02), MSFT: 49.93 (+0.32), INTC: 33.87 (+0.19), GRPN: 7.79 (+0.02), CMCSA: 54.21 (-0.09), AAPL: 113.95 (+1.13), SUSQ: 13.12 (+0.06), CSCO: 26.05 (+0.37)
Final Glance: Biotechnology companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Midday Glance: Biotechnology companies
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.28 (-2.92), AMGN: 158.21 (-2.64), CELG: 103.40 (-4.03)
Gilead prices debt offering
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:19AM CST
GILD: 101.28 (-2.92)
Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:44AM CST
Gilead Sciences which is in the Biotechnology space, saw EPS growth of nearly 11% last year, and is looking great for this year too.
GILD: 101.28 (-2.92)
Gilead prices USD4bn senior unsecured notes in three tranches
M2 - Thu Nov 13, 6:01AM CST
Biopharmaceutical company Gilead Sciences (NasdaqGS:GILD) said on Wednesday that it has priced its USD4bn senior unsecured notes in a public offering.
GILD: 101.28 (-2.92)
Gilead Prices $4 Billion of Senior Unsecured Notes
Business Wire - Wed Nov 12, 4:59PM CST
Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten, registered public offering, consisting of three tranches:
GILD: 101.28 (-2.92)
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:00PM CST
Gilead Sciences, Inc. (GILD) announced pooled data from certain phase II and phase III studies evaluating Harvoni.
AGN: 197.30 (+1.09), JNJ: 108.59 (-0.48), GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Gilead Sciences Falls 1.03% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)
Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 1.03% Sell Off
Comtex SmarTrend(R) - Wed Nov 12, 3:37PM CST
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $105.70 to a high of $107.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $106.33 on volume of 12.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 101.28 (-2.92)
Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
Small Pharma Analyst - at Seeking Alpha - Wed Nov 12, 2:25PM CST
GILD: 101.28 (-2.92), ABBV: 63.44 (-0.19)
Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View
Shock Exchange - at Seeking Alpha - Wed Nov 12, 2:13PM CST
GILD: 101.28 (-2.92), MRK: 58.97 (-0.57)
(0)
(0)Gilead Sciences Inc. (GILD) Stock Research Links
Scroll down for more posts ▼